Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Michael Fu
Research Area(s) / Expertise: Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Professor Michael Fu is currently a nucleus member of working group of heart failure with preserved ejection fraction, Heart Failure Association, European Society of Cardiology, and an nucleus member of the National Working Group of Heart Failure in Sweden. Michael Fu is an expert in heart failure with research focus on epidemiology, clinical phenotype, prognosis and its risk factors,… View more
Epidemiology and Clinical Features of HFpEF
Author(s): Kanako Teramoto , Tiew-Hwa Katherine Teng , Chanchal Chandramouli , et al Added: 1 year ago

Heart Failure
New Insights on HFpEF Treatment
Author(s): Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al Added: 2 weeks ago

Standards & Guidelines

Heart Failure
HF 2022: Heart Failure Highlights of 2022 with Prof Cleland
Author(s): John GF Cleland Added: 1 year ago
Prof John Cleland (University of Glasgow & Glasgow Royal Infirmary, Glasgow, UK) joined us to talk about heart failure management highlights in 2022 including a new phenotype, HFsnEF; available and new treatment options; news on SGLT2is and more. Recorded at Heart Failure 2022, Madrid. Videographer: Tom Green Editor: Mirjam Boros View more

Standards & Guidelines

Heart Failure
Author(s): Yury Lopatin Added: 3 years ago
In 2016, the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC)1 introduced heart failure (HF) with mid-range ejection fraction (HFmrEF) as a distinct phenotype. This distinction was expected to stimulate research on the underlying characteristics, pathophysiology and treatment of patients with HFmrEF. Indeed, in the following… View more

Heart Failure
Cardiovascular Involvement in Fabry’s Disease
Author(s): Emanuele Monda , Luigi Falco , Giuseppe Palmiero , et al Added: 8 months ago

Heart Failure
Author(s): Cristiana Vitale , Ilaria Spoletini , Giuseppe Rosano Added: 3 years ago
Because of the ageing population in industrialised countries, the prevalence of cardiovascular disease has dramatically increased.1 In particular, heart failure (HF) has become a major public health problem and the leading cause of morbidity, hospitalisation and mortality in older people.2,3 Patients with HF, especially the oldest, are often characterised by a “vulnerability status” due to the… View more

Heart Failure
Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
Author(s): Davide Margonato , Simone Mazzetti , Renata De Maria , et al Added: 3 years ago
Heart failure (HF) is a complex syndrome caused by functional and structural abnormalities of the left ventricle (LV) resulting in a combination of typical signs and symptoms. Historically, HF has been classified according to LV ejection fraction (EF) as either HF with reduced EF (HFrEF; LVEF <40%) or HF with preserved EF (HFpEF; LVEF >50%).1,2 The 2016 European Society of Cardiology (ESC)… View more

Heart Failure
Author(s): Simon Stewart , Trine T Moholdt , Louise M Burrell , et al Added: 3 years ago
There is universal acknowledgement that climate change and extreme weather events pose an increasing threat to global health.1,2 Precisely how this will affect patterns of disease is open to conjecture. For example, while it is predicted that increasingly warmer temperatures and more intense heat waves will provoke more cardiovascular, respiratory and renal events, a corollary reduction in… View more

Heart Failure
Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
Author(s): Sebastian Rosch , Karl-Philipp Rommel , Markus Scholz , et al Added: 3 years ago
Heart failure with preserved ejection fraction (HFpEF) is a common disease with rapidly increasing incidence and prevalence due to demographic changes.1 Well-known risk factors, such as metabolic syndrome (arterial hypertension, diabetes, obesity and dyslipidaemia), chronic kidney disease and AF, predispose to the development of HFpEF, especially in older people. Establishing the clinical… View more

Heart Failure